Kritzia Merced1, Zac E Imel1, Scott A Baldwin1, Heidi Fischer1, Tae Yoon1, Christine Stewart1, Greg Simon1, Brian Ahmedani1, Arne Beck1, Yihe Daida1, Sam Hubley1, Rebecca Rossom1, Beth Waitzfelder1, John E Zeber1, Karen J Coleman1. 1. Department of Educational Psychology, University of Utah, Salt Lake City (Merced, Imel); Department of Clinical Psychology, Brigham Young University, Provo, Utah (Baldwin); Kaiser Permanente, Pasadena, California (Fischer, Yoon, Coleman), Seattle (Stewart, Simon), Denver (Beck), and Honolulu (Daida, Waitzfelder); Center for Health Policy and Health Services Research, Henry Ford Health System, Detroit (Ahmedani); University of Colorado School of Medicine, Aurora (Hubley); HealthPartners Institute, Minneapolis (Rossom); Veterans Evidence-Based Research, Dissemination, and Implementation Center, South Texas Veterans Health Care System, San Antonio (Zeber).
Abstract
OBJECTIVE: Disparities in diagnosis of mental health problems and in access to treatment among racial-ethnic groups are apparent across different behavioral conditions, particularly in the quality of treatment for depression. This study aimed to determine how much disparities differ across providers. METHODS: Bayesian mixed-effects models were used to estimate whether disparities in patient adherence to antidepressant medication (N=331,776) or psychotherapy (N=275,095) were associated with specific providers. Models also tested whether providers who achieved greater adherence to treatment, on average, among non-Hispanic white patients than among patients from racial-ethnic minority groups attained lower disparities and whether the percentage of patients from racial-ethnic minority groups in a provider caseload was associated with disparities. RESULTS: Disparities in adherence to both antidepressant medication and psychotherapy were associated with the provider. Provider performance with non-Hispanic white patients was negatively correlated with provider-specific disparities in adherence to psychotherapy but not to antidepressants. A higher proportion of patients from racial-ethnic minority groups in a provider's caseload was associated with lower adherence among non-Hispanic white patients, lower disparities in adherence to psychotherapy, and greater disparities in adherence to antidepressant medication. CONCLUSIONS: Adherence to depression treatment among a provider's patients from racial-ethnic minority groups was related to adherence among that provider's non-Hispanic white patients, but evidence also suggested provider-specific disparities. Efforts among providers to decrease disparities might focus on improving the general skill of providers who treat more patients from racial-ethnic minority groups as well as offering culturally based training to providers with notable disparities.
OBJECTIVE: Disparities in diagnosis of mental health problems and in access to treatment among racial-ethnic groups are apparent across different behavioral conditions, particularly in the quality of treatment for depression. This study aimed to determine how much disparities differ across providers. METHODS: Bayesian mixed-effects models were used to estimate whether disparities in patient adherence to antidepressant medication (N=331,776) or psychotherapy (N=275,095) were associated with specific providers. Models also tested whether providers who achieved greater adherence to treatment, on average, among non-Hispanic white patients than among patients from racial-ethnic minority groups attained lower disparities and whether the percentage of patients from racial-ethnic minority groups in a provider caseload was associated with disparities. RESULTS: Disparities in adherence to both antidepressant medication and psychotherapy were associated with the provider. Provider performance with non-Hispanic white patients was negatively correlated with provider-specific disparities in adherence to psychotherapy but not to antidepressants. A higher proportion of patients from racial-ethnic minority groups in a provider's caseload was associated with lower adherence among non-Hispanic white patients, lower disparities in adherence to psychotherapy, and greater disparities in adherence to antidepressant medication. CONCLUSIONS: Adherence to depression treatment among a provider's patients from racial-ethnic minority groups was related to adherence among that provider's non-Hispanic white patients, but evidence also suggested provider-specific disparities. Efforts among providers to decrease disparities might focus on improving the general skill of providers who treat more patients from racial-ethnic minority groups as well as offering culturally based training to providers with notable disparities.
Entities:
Keywords:
Bayesian multilevel modeling; adherence; cross-cultural issues; cultural competence; provider effects; racial-ethnic mental health disparities; treatment adherence
Authors: Joseph R Betancourt; Alexander R Green; J Emilio Carrillo; Owusu Ananeh-Firempong Journal: Public Health Rep Date: 2003 Jul-Aug Impact factor: 2.792
Authors: John E Zeber; Karen J Coleman; Heidi Fischer; Tae K Yoon; Brian K Ahmedani; Arne Beck; Samuel Hubley; Zac E Imel; Rebecca C Rossom; Susan M Shortreed; Christine Stewart; Beth E Waitzfelder; Greg E Simon Journal: Depress Anxiety Date: 2017-11-02 Impact factor: 6.505